These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1422947)
1. Secular trends in the incidence of postmenopausal vertebral fractures. Cooper C; Atkinson EJ; Kotowicz M; O'Fallon WM; Melton LJ Calcif Tissue Int; 1992 Aug; 51(2):100-4. PubMed ID: 1422947 [TBL] [Abstract][Full Text] [Related]
2. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. Cooper C; Atkinson EJ; O'Fallon WM; Melton LJ J Bone Miner Res; 1992 Feb; 7(2):221-7. PubMed ID: 1570766 [TBL] [Abstract][Full Text] [Related]
3. [Vertebral fracture: a major risk factor for osteoporosis]. Krieg MA; Lamy O Praxis (Bern 1994); 2004 Feb; 93(9):321-8. PubMed ID: 15060973 [TBL] [Abstract][Full Text] [Related]
4. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis. Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559 [TBL] [Abstract][Full Text] [Related]
5. Vertebral fracture in postmenopausal Chinese women: a population-based study. Cui L; Chen L; Xia W; Jiang Y; Cui L; Huang W; Wang W; Wang X; Pei Y; Zheng X; Wang Q; Ning Z; Li M; Wang O; Xing X; Lin Q; Yu W; Weng X; Xu L; Cummings SR Osteoporos Int; 2017 Sep; 28(9):2583-2590. PubMed ID: 28560474 [TBL] [Abstract][Full Text] [Related]
6. Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. Boonen S; Adachi JD; Man Z; Cummings SR; Lippuner K; Törring O; Gallagher JC; Farrerons J; Wang A; Franchimont N; San Martin J; Grauer A; McClung M J Clin Endocrinol Metab; 2011 Jun; 96(6):1727-36. PubMed ID: 21411557 [TBL] [Abstract][Full Text] [Related]
8. No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis. Hansen MA; Overgaard K; Nielsen VA; Jensen GF; Gotfredsen A; Christiansen C Osteoporos Int; 1992 Sep; 2(5):241-6. PubMed ID: 1392263 [TBL] [Abstract][Full Text] [Related]
9. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509 [TBL] [Abstract][Full Text] [Related]
10. [No increase in the prevalence of vertebral fractures among postmenopausal women over a 10-year period]. Hansen MA; Overgaard K; Nielsen VA; Jensen G; Gotfredsen A; Christiansen C Ugeskr Laeger; 1993 Aug; 155(31):2392-6. PubMed ID: 8346589 [TBL] [Abstract][Full Text] [Related]
11. Frequency, distribution and severity of prevalent osteoporotic vertebral fractures in postmenopausal women. Kilincer C; Kabayel DD; Cagli B; Unlu E; Wicki B; Ozdemir F Turk Neurosurg; 2013; 23(4):476-83. PubMed ID: 24101267 [TBL] [Abstract][Full Text] [Related]
12. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study. McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495 [TBL] [Abstract][Full Text] [Related]
13. [Rheumatology and osteoporosis (RETOSS): a vision of postmenopausal osteoporosis in rheumatology departments throughout Spain]. Bernad Pineda M; González Fernández CM; Fernández Prada M; Fernández Campillo J; Maeso Martín R; Garcés Puentes MV Reumatol Clin; 2011; 7(1):13-9. PubMed ID: 21794774 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model. Cawston H; Maravic M; Fardellone P; Gauthier A; Kanis JA; Compston J; Borgström F; Cooper C; McCloskey E Arch Osteoporos; 2012; 7():237-46. PubMed ID: 23060309 [TBL] [Abstract][Full Text] [Related]
15. The population-based prevalence of osteoporotic vertebral fracture and densitometric osteoporosis in postmenopausal women over 50 in Valencia, Spain (the FRAVO study). Sanfélix-Genovés J; Reig-Molla B; Sanfélix-Gimeno G; Peiró S; Graells-Ferrer M; Vega-Martínez M; Giner V Bone; 2010 Sep; 47(3):610-6. PubMed ID: 20601286 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. Nevitt MC; Cummings SR; Stone KL; Palermo L; Black DM; Bauer DC; Genant HK; Hochberg MC; Ensrud KE; Hillier TA; Cauley JA J Bone Miner Res; 2005 Jan; 20(1):131-40. PubMed ID: 15619679 [TBL] [Abstract][Full Text] [Related]
17. Risk of new vertebral fracture in the year following a fracture. Lindsay R; Silverman SL; Cooper C; Hanley DA; Barton I; Broy SB; Licata A; Benhamou L; Geusens P; Flowers K; Stracke H; Seeman E JAMA; 2001 Jan; 285(3):320-3. PubMed ID: 11176842 [TBL] [Abstract][Full Text] [Related]
18. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. Chang KP; Center JR; Nguyen TV; Eisman JA J Bone Miner Res; 2004 Apr; 19(4):532-6. PubMed ID: 15005838 [TBL] [Abstract][Full Text] [Related]
19. Secular trends in the incidence of hip fractures. Melton LJ; O'Fallon WM; Riggs BL Calcif Tissue Int; 1987 Aug; 41(2):57-64. PubMed ID: 3115545 [TBL] [Abstract][Full Text] [Related]
20. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation. Siris E; Adachi JD; Lu Y; Fuerst T; Crans GG; Wong M; Harper KD; Genant HK Osteoporos Int; 2002 Nov; 13(11):907-13. PubMed ID: 12415439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]